CareDx announced that the Department of Justice has concluded its investigation into CareDx with no finding of wrongdoing and declined to take any further action. In a Court document unsealed on October 7, 2024, the DOJ indicated that it is declining to intervene in a qui tam action filed by a former CareDx employee. The decision by the DOJ follows the decision made by the U.S. SEC in September 2023 to close its investigation and take no action against the company. The company believes the closure of the DOJ’s investigation underscores that the underlying allegations, which have now been reviewed by two separate government agencies, were meritless, reinforcing its confidence in the integrity of its operations. The qui tam complaint, which was filed under seal on February 12, 2021, in the federal district court for the Eastern District of New York, is now unsealed. CareDx will continue to vigorously defend itself should the former employee choose to proceed with this litigation.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDNA:
- CareDx Arranges Amicable Exit for Executive Alexander Johnson
- CareDx hiring of industry vet Kennedy a positive, says BTIG
- CareDx Announces Key Executive Appointments and Investor Day
- CareDx appoints Keith Kennedy COO, Jessica Meng CCO
- Foot Locker trips after earnings, Kohl’s posts Q2 beat: Morning Buzz